Skip to main content
  • linkedin
New Website Coming Soon!
Hit enter to search or ESC to close
Close Search
Hepion PharmaceuticalsHepion Pharmaceuticals
Menu
  • About
    • Company Overview
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnering
  • Liver Disease
    • Overview
    • Non-alcoholic Steatohepatitis (NASH)
    • Hepatocellular Carcinoma (HCC)
    • Viral Hepatitis
  • AI-POWR™
  • Pipeline
    • Overview
    • Rencofilstat
    • Therapeutic Strategy
    • Clinical Trials
    • Publications
    • Expanded Access Policy
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
    Hepion Pharmaceuticals

    Hepion in the News

     About Hepion
    Recent News
     Contact Us
    Hepion
    Hepion In Industry News, Videos

    Voclosporin Success Story [via Applied Pharmaceutical Innovation]

    Read More
    Hepion
    Hepion In Industry News

    ‘Huge potential opportunity’ for Edmonton Pharmaceutical Industry as FDA Approves Aurinia Lupus Drug [Taproot Edmonton]

    https://edmonton.taproot.news/news/2021/02/03/huge-potential-opportunity-for-edmonton-pharmaceutical-industry-as-fda-approves-aurinias-lupus-drug
    Hepion
    Hepion In Media Placements

    Hepion Pharmaceuticals employing artificial intelligence to tackle NASH [BioTuesdays]

    https://hepionpharma.com/wp-content/uploads/2020/11/BioTuesdays-November-2020.pdf
    Hepion
    Hepion In Media Placements, Videos

    Hepion Tackles NASH in P2 with Cyclophilin Inhibitor [Breaking Biotech]

    Read More
    Hepion
    Hepion In Media Placements

    Robert Foster Discusses Drug Development on the Danielle Smith Show

    https://hepionpharma.com/wp-content/uploads/2020/09/Alberta-Based-Ground-Breaking-COVID-19-Treatment-Rencofilstat.mp3

    https://hepionpharma.com/wp-content/uploads/2020/09/Alberta-Based-Ground-Breaking-COVID-19-Treatment-Rencofilstat.mp3  

    Read More
    Hepion
    Hepion In Media Placements

    Robert Foster Discusses Drug Development on Humble & Fred Morning Radio Podcast

    https://hepionpharma.com/wp-content/uploads/2020/08/Humble-and-Fred-200827-dr-robert-foster-clip.mp3

    [audio src="https://hepionpharma.com/wp-content/uploads/2020/08/Humble-and-Fred-200827-dr-robert-foster-clip.mp3" /]

    Read More
    Hepion
    Hepion In Media Placements

    Amidst a global pandemic, two biotech companies offer innovative solutions [BioTuesdays]

    https://biotuesdays.com/2020/03/31/amidst-a-global-pandemic-two-biotech-companies-offer-innovative-solutions/
    Hepion
    Hepion In Media Placements, Videos

    Rencofilstat (CRV431) Mechanism of Action [Video]

    Read More
    Hepion
    Hepion In Media Placements

    Breakthrough lupus drug discovered in Edmonton passes final testing phase [Global News]

    https://globalnews.ca/news/6273515/lupus-drug-edmonton-discovery/
    Hepion
    Hepion In Media Placements

    Research institute launched out of U of A attracts $25 million in investments [Edmonton Journal]

    https://edmontonjournal.com/business/local-business/research-institute-launched-out-of-u-of-a-attracts-25-million-in-investments
    • « Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • Next »
    Share Share Share

    Media Contact

    info@hepionpharma.com

    Tweets by Hepion Pharma
    Get Important News and Updates by Email Subscribe
    • linkedin

    © 2026 Hepion Pharmaceuticals | Disclaimer & Terms of Use | WDDI

    Close Menu
    • About
      • Company Overview
      • Executive Team
      • Board of Directors
      • Scientific Advisory Board
      • Partnering
    • Liver Disease
      • Overview
      • Non-alcoholic Steatohepatitis (NASH)
      • Hepatocellular Carcinoma (HCC)
      • Viral Hepatitis
    • AI-POWR™
    • Pipeline
      • Overview
      • Rencofilstat
      • Therapeutic Strategy
      • Clinical Trials
      • Publications
      • Expanded Access Policy
    • Newsroom
    • Investors
      • Investor Overview
      • Press Releases
      • Events
      • Presentations
      • Company Information
      • Stock Information
      • SEC Filings
      • Corporate Governance
    • Contact
      • Contact Us
      • Careers
    • linkedin